Bibliography
- RICE WG, TURPIN JA: Virus-encoded zinc fingers as for antiviral chemotherapy. Rev. Med. Viral. (1996) 6:187–199.
- •An interesting review on the early tentative development of antiviral agents that target zinc finger proteins.
- RICE WG, SUPKO JG, MALSPEIS L et al: Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science (1995) 270:1194–1197.
- RICE WG, TURPIN JA, SCHAEFFER CA et al: Evaluation of selected chemo types in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors. J. Med. Chem. (1996) 39:3606–3616.
- HATHOUT Y, FABRIS D, HAN MS, SOWDER RC,HENDERSON LE, FENSELAU C: Characterization of in the oxidation of zinc fingers in human immunodeficiency virus Type 1 nucleocapsid protein P7. Drug Metab. Dispos. (1996) 24:1395–1400.
- REIN A, OTT DE, MIRRO J, ARTHUR LO, RICE WG,HENDERSON LE: Inactivation of murine leukemia virus by compounds that react with the zinc finger in the viral nucleocapsid protein Virol (1996) 70:4966–4972.
- SCOZZAFAVA A, SUPURAN CT: Carbonic anhydraseinhibitors. Synthesis of N-morpholyl-thiocarbonyl sulfenylamino aromatic/heterocyclic sulfonamides and their interaction with isozymes 1,11 and W. Bioorg. Med. Chem. Lett. (2000) 10:1117–1120.
- CONANT MA: Immunomodulatory therapy in themanagement of viral infections in patients with HIV infection. J. Am. Acad. Dermatol (2000) 43:27–30.
- WEDEMEYER WJ, WELKER E, NARAYAN M, SCHERAGAHA: Disulfide bonds and protein folding. Biochemistry (2000) 39:4207–4216.
- AUBORN KJ, CARTER TH: Treatment of papillomavirusgynecologic infections. Clin. Lab. Med. (2000) 20:407–422.
- MCGLENNEN RC: Human papillomavirus oncogenesis.Clin. Lab. Med. (2000) 20:383–406.
- HARWOOD CA, SURENTHERAN T, MCGREGOR JM et al:Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocom-petent individuals. J. Med. Virol. (2000) 61:289–297.
- CARR J, GYORFI T: Human papillomavirus: epidemi-ology, transmission and pathogenesis. Clin. Lab. Med. (2000) 20:235–255.
- CHEN JJ, REID CE, BAND V ANDROPHY EJ: Interaction ofpapillomavirus E6 oncoproteins with a putative calcium-binding protein. Science (1995) 269:529–531.
- TONG X, HOWLEY PM: The bovine papillomavirus E6oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc. Natl. Acad. Sci. USA (1997) 94:4412–4417.
- KAO WH, BEAUDENON SL, TALIS AL, HUIBREGTSE JM, HOWLEY PM: Human papillomavirus Type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. j Virol. (2000) 74:6408–6417.
- SASAGAWA T, MINEMOTO Y, BASHA W et al: A new PCR-based assay amplifies the E6-E7 genes of most mucosal human papillomaviruses. Virus Res. (2000) 67:127–139.
- GROSSMAN SR, LAIMINS LA: E6 protein of humanpapillomavirus Type 18 binds zinc. Oncogene (1989) 4:1089–1093.
- SUPURAN CT, BRIGANTI F, TILLI S, CHEGWIDDEN WR, SCOZZAFAVA A: Carbonic anhydrase inhibitors. Sulfonamides as antitumor agents? Bioorg. Med. Chem. (2000) 8: (In Press).
- FREDERICKSON CJ, KASARSKIS EJ, RINGO D, FREDER-ICKSON RE: A quinoline fluorescence method for visualizing and assaying the histochemically reactive zinc (Bouton zinc) in the brain./ Neorosci. Meth.. (1987) 20 :91–103.
- SUPURAN CT, SCOZZAFAVA A: Carbonic anhydrase inhibitors and their therapeutic potential. Exp. Opin. Ther. Patents (2000) 10:575–600.
- •An exhaustive review on the therapeutic and diagnostic applications of the sulphonamide carbonic anhydrase inhibitors.